Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    6%
    Check dated 2025-10-05T10:03:58.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Update terminology to Softer/standardized phrasing: 'Squamous cell carcinoma of the head and neck' replaces 'Head and neck squamous cell carcinoma'; version bumped from v3.0.2 to v3.1.0.
    Difference
    1%
    Check dated 2025-09-28T03:09:57.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed as a minor UI change; no other substantive content changes were detected.
    Difference
    0.4%
    Check dated 2025-09-13T17:10:55.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.4%
    Check dated 2025-09-06T14:35:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as resources related to head and neck squamous cell carcinoma. However, several key terms and drug names, including pembrolizumab and acalabrutinib, have been removed.
    Difference
    7%
    Check dated 2025-08-30T11:22:35.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:32:15.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.